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Abstract: 
Inositol Inpp5k (or Pps, SKIP) is a member of the inositol polyphosphate 5-
phosphatases family with a poorly characterized function in vivo. Here, we explored 
the function of this inositol 5-phosphatase in mice and cells overexpressing the 42 
kDa mouse Inpp5k protein. Inpp5k transgenic mice present defects in water 
metabolism characterized by a reduced plasma osmolality at baseline, a delayed 
urinary water excretion following a water load, and an increased acute response to 
vasopressin. These defects are associated with the expression of the Inpp5k 
transgene in renal collecting ducts and with alterations in the arginine 
vasopressin/aquaporin-2 signalling pathway in this tubular segment. Analysis in a 
mouse collecting duct mCCD cell line revealed that Inpp5k overexpression leads to 
increased expression of the arginine vasopressin receptor type 2 and increased 
cAMP response to arginine vasopressin, providing a basis for increased aquaporin-2 
expression and plasma membrane localization with increased osmotically-induced 
water transport. Altogether, our results indicate that Inpp5k 5-phosphatase is 
important for the control of the arginine vasopressin/aquaporin-2 signalling pathway 
and water transport in kidney collecting ducts.    
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Introduction: 
Phosphatidylinositol (4,5)-bisphosphate (PtdIns(4,5)P2) and phosphatidylinositol 
(3,4,5)-trisphosphate (PtdIns(3,4,5)P3) demonstrate second messenger functions in 
multiple biological processes. PtdIns(4,5)P2 controls, among others, the dynamic 
turnover of actin cytoskeleton, assembly/disassembly of vesicular coats, secretion, 
gene expression and the fate of endocytic vesicles [13, 17, 29, 40]. It also regulates 
the activity of many ion channels and transporters [35, 36]. PtdIns(4,5)P2 is mainly 
localized in the inner leaflet of plasma membranes, but smaller pools have been 
detected in intracellular membranes, including Golgi, endoplasmic reticulum, 
endosomes and lamellipodia [13]. Mechanistically, a very large number of proteins 
are recruited to PtdIns(4,5)P2 via pleckstrin homology (PH), phagocyte oxidase (PX), 
Fab1p, YOTB, Vac1p and EEA1 (FYVE), epsin N-terminal homology (ENTH) 
domains or through small patches of basic amino acids [13, 18, 28]. PtdIns(4,5,)P2 
also serves as precursor of five essential signalling molecules: diacylglycerol, inositol 
(1,4,5)-trisphosphate, PtdIns4P, PtdIns5P and PtdIns(3,4,5)P3 [13, 17]. In non 
stimulated cells, PtdIns(3,4,5)P3 levels are very low in the plasma membrane, 
reaching ~0.1% of the level of PtdIns(4,5)P2 [13, 17]. Upon cell activation, 
PtdIns(3,4,5)P3 levels are transiently increased by a factor ranging from 2- to 100-
fold. This phosphoinositide is implicated in the control of cell survival, growth and 
proliferation, resistance to apoptosis, regulation of cytoskeleton dynamics, membrane 
trafficking, cell migration, and many of the metabolic responses to insulin [12, 13]. 
PtdIns(3,4,5)P3 regulates a wide variety of effector proteins primarily by binding and 
recruiting specific proteins.  
In mammalian cells, PtdIns(4,5)P2 and/or PtdIns(3,4,5)P3 are substrates for several 
members of the phosphoinositide 5-phosphatases family, including Inppl1 (or 
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SHIP2), Inpp5e and Inpp5k (or SKIP, for Skeletal muscle and Kidney enriched 
Inositol Phosphatase, and Pps, for Putative Phosphatase) [2, 7, 30, 32, 33]. These 
enzymes tightly control the level of the above-mentioned phosphoinositides in a 
tissue-, cellular-, subcellular- and signalling cascade-specific way. Importantly, 
inactivation or overexpression of most members of this family has been associated 
with diseases in mouse and man [3, 30, 32, 33]. For example, Inpp5e is localized in 
the primary cilium of differentiated/quiescent cells; mice and man with genetic 
alterations in the Inpp5e gene develop ciliopathies [6, 22]. SHIP2 knock-out mice are 
resistant to high fat diet-induced obesity and have glucose metabolism alterations 
[10, 34]; polymorphisms in the SHIP2 gene have been identified in cohorts of type 2 
diabetic patients, and overexpression of SHIP2 in transgenic mice is associated with 
glucose metabolism and insulin sensitivity defects [25, 26, 31].  
Inpp5k is a PtdIns(4,5)P2 and PtdIns(3,4,5)P3 5-phosphatase. It is highly expressed 
in human skeletal muscles and kidney, hence its previous name SKIP [19]. In N1E-
115 neuroblastoma cells, human Inpp5k regulates the actin cytoskeleton [19]. Human 
Inpp5k is translocated from the endoplasmic reticulum to plasma membrane ruffles 
following activation by EGF and insulin in Cos-7 and skeletal muscle C2C12 cell 
lines, respectively [16, 39]. Activation of PKB and p70 S6 kinases as well as GLUT4 
glucose transporter translocation to the plasma membrane and membrane ruffles 
formation were significantly decreased in human Inpp5k-transfected and insulin-
stimulated CHO cells [20]. Mice totally deficient for Inpp5k die during embryonic life 
for still unknown reason; Inpp5k+/- mice have increased insulin sensitivity in skeletal 
muscles, confirming the results obtained in different cell lines [21]. However, the role 
of Inpp5k in the kidney, another tissue where the phosphatase has been reported to 
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be highly expressed, and its potential implication in a metabolic or a pathologic 
process in this tissue remain undefined. 
In order to explore the function of Inpp5k in vivo, we generated and characterized a 
transgenic mouse line expressing the mouse Inpp5k 5-phosphatase in many tissues. 
Our in vivo and in vitro results reveal that overexpression of Inpp5k in kidney 
collecting duct cells is associated with defects in water handling paralleled by 
alterations in the arginine vasopressin (AVP)/aquaporin-2 (AQP2) signalling pathway 
resulting in impaired osmoregulation.  
 7
Materials and Methods: 
RNA analysis in mouse tissues and cells: For Northern blot analysis, total RNA 
was extracted from mouse tissues using the TriPure Isolation reagent (Roche 
Applied Sciences) and loaded (10 µg/lane) on agarose gel. A 944 bp DNA fragment 
of the mouse Inpp5k cDNA served as a radiolabeled probe. A radiolabeled probe 
consisting in a 600 bp DNA fragment of the mouse hypoxanthine-guanine 
phosphoribosyltransferase (HPRT) cDNA served as loading control.  
For RT-PCR analysis on FACS-purified populations of dendritic cells, mast cells, 
macrophages, neutrophils, eosinophils, T and B lymphocytes, RNA was extracted 
and reverse-transcribed using random hexamers. cDNA was amplified by PCR using 
forward and reverse primers located in exon 8 and exon 12 of the mouse Inpp5k 
gene, respectively (see Suppl. Table 1 for the primers sequence; annealing 
temperature: 55.5°C; 30 cycles). For RT-PCR and real-time RT-PCR analysis on 6 
month-old mouse kidney and brain and on mCCD cells, total RNA and cDNA were 
obtained as described [24]. The primers (Suppl. Table 1) were designed using 
Primer3. Changes in target gene mRNA levels were determined in duplicate by 
relative RT-qPCR with a CFX96TM Real-Time PCR Detection System (Bio-Rad 
Laboratories, Hercules, CA) using iQTM SYBR Green Supermix (Bio-Rad) detection 
of single PCR product accumulation. The PCR conditions, the negative controls, the 
preparation of the standard curves and the calculation of the reaction efficiencies 
were as previously described [1]. 
Antibodies: An affinity-purified rabbit antibody against the RSFLREDTLYEPEPQI 
carboxy-terminal mouse Inpp5k peptide was obtained from Eurogentec, Liège, 
Belgium. Pre-incubation of the anti-Inpp5k antibody with the immunogenic peptide 
resulted in the disappearance of the signal in Western blot, immunoprecipitation and 
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immunohistochemistry analyses (data not shown). Rabbit polyclonal antibodies 
raised against the AQP2 (Sigma-Aldrich), phosphorylated Ser256 AQP2 (p-AQP2) [8]  
and NKCC2 (Millipore), sheep anti-megalin (a gift from P. Verroust, Paris, France) 
[9], mouse monoclonal antibodies against the M2 clone of Flag® tag (FITC-
conjugated, Sigma-Aldrich) and  β-actin (Sigma-Aldrich), and Alexa633-labelled 
secondary anti-IgG antibodies (Invitrogen, Belgium) were also used.  
Protein analysis: Tissues were homogenized in a buffer containing NP-40 (1%), 
Tris-HCl pH 8 (50 mM), NaCl (150 mM), and protease inhibitors (CompleteTM, Roche 
Diagnostics GmbH). Cell lysates were obtained by solubilizing frozen pellets in lysis 
buffer containing Complete Mini (Roche), followed by sonication and centrifugation at 
16,000 g for 1 min at 4°C. When needed, total membrane and cytosolic fractions 
were separated by centrifugation (100.000g for 2h). Protein concentrations were 
determined using BCA protein assay (Pierce, Aalst, Belgium). Cell and tissue 
samples were normalized for protein levels, diluted in Laemmli sample buffer, 
separated by SDS-PAGE in reducing conditions, and blotted onto nitrocellulose or 
PVDF membranes. After blocking with non-fat milk, membranes were incubated 
overnight at 4°C with the primary antibody, washed, incubated with peroxidase-
labeled secondary antibody, and visualized with enhanced chemiluminescence 
(Perkin Elmer).  
When indicated, protein analysis was performed after immunoprecipitation of the 
Inpp5k protein either with the anti-Flag or the anti-Inpp5k rabbit polyclonal antibodies 
and protein A Sepharose CL-4B (Amersham). In these conditions, a HRP-coupled 
anti-Flag monoclonal antibody and a biotin-coupled anti-Inpp5k polyclonal antibody 
were used as primary antibodies in the Western blotting. For surface biotinylation 
assay, 10-day old confluent monolayers of mCCD cells were incubated with Sulfo-
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NHS-biotine (1.5mg/ml, Pierce) at 4°C. Excess biotine was quenched by incubation 
with 100mM glycine and cells were lysed in Ripa buffer containing protease 
inhibitors. Lysate was centrifugated and its supernatant was incubated with 
streptavidine-conjugated agarose droplets (Pierce) to purify apical membranes from 
the cytosolic fraction. Proteins were extracted from renal cortex and medulla samples 
as described [24].  
Malachite phosphatase assay: Inpp5k protein was immunoprecipitated from kidney 
extracts as described above. Inpp5k phosphoinositide phosphatase activity was 
measured with a phosphate release assay using an acidic malachite green. Briefly, 
Inpp5k protein immunoprecipitates were incubated with 100 µM of either 
PtdIns(3,4,5)P3 di-C16 or PtdIns(4,5)P2 di-C16 in mixed vesicles of Ptdserine for 10 
min at 37°C. Reactions were stopped by addition of EDTA. After centrifugation, 
supernatants were incubated with malachite green reagent for 10 min. Absorbance 
was measured at 650 nm. As negative controls, we used the anti-Inpp5k antibody 
preincubated with the immunogenic peptide before adding the protein extract, and 
the anti-Flag antibody without addition of any kidney extract. Inorganic phosphate 
release was quantified by comparison to a standard curve of KH2PO4 in dH2O.  
Lentivirus construction and production: pWPXLd, psPAX2 and pMD2.G plasmids 
were obtained from D. Trono (Ecole Polytechnique Fédérale de Lausanne, 
Lausanne, Switzerland). The chicken β actin promoter/enhancer, the 
cytomegalovirus immediate-early enhancer (altogether referred as the CAGG 
promoter), a β globin intron, the eGFP cDNA flanked by loxP sites and the 
octapeptide Flag amino-terminal-tagged mouse Inpp5k cDNA corresponding to the 
42 kDa isoform of the Inpp5k protein (NM-008916) were introduced between the 2 
LTR sequences in the pWPXLd plasmid. This plasmid was named 
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pWPXLd/GFP/Inpp5k. A pWPXLd/Inpp5k plasmid was obtained after transformation 
of 294 Cre-expressing bacteria with the pWPXLd/GFP/Inpp5k plasmid. Recombinant 
lentiviruses were obtained after transfection of 293T cells with the 
pWPXLd/GFP/Inpp5k, psPAX2 and pMD2.G plasmids. After 2 days, the lentivirus-
containing supernatant was harvested, purified and concentrated by 
ultracentrifugation, and resuspended in KSOM embryo culture medium (Specialty 
Media). The concentrated lentiviral suspension was titrated by infection of 293T cells 
for 2 days followed by GFP expression analysis using a flow cytometer.   
Production of lentigenic mice: 2-4 cell embryos were recovered from 
superovulated (C57BL/6 x Balb/c)F1 female mice crossed with F1 males. Embryos 
were depellucided with tyrode acid (Sigma) and incubated with 5 to 10 x 103 lentiviral 
particles in a drop of KSOM medium under mineral oil (Sigma). After 2 days at 37°C 
and 5% CO2, viable embryos were rinsed several times with M2 embryo culture 
medium (Sigma) and reimplanted in the uterine horns of pseudogestant CD1 females 
(Harlan). Newborns were screened for GFP expression in the tail by fluorescent 
microscopy (Nikon Eclipse TE300). GFP/Inpp5k transgenic founders were crossed 
with PGK-Cre mice in order to remove the GFP cDNA from the inserted transgene 
and to obtain Inpp5k transgenic mice. GFP/Inpp5k and Inpp5k transgenic mice were 
backcrossed with C57BL/6 mice for 5 generations before analysis. No Cre transgene 
was left in the experimental mice. Non transgenic littermates resulting from the 
crossing between Inpp5k transgenic mice and C57BL/6 mice, as well as age-
matched GFP/Inpp5k transgenic mice served as controls. All animal studies were 
authorized by The Animal Care Use and Review Committee of the Université Libre 
de Bruxelles.   
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DNA analysis: Genomic DNA was extracted from tail tips and analyzed by Southern 
blotting and PCR. DNA was digested with EcoRI or SpeI, loaded on an agarose gel 
and transferred onto a nitrocellulose membrane. A 950 bp DNA fragment of the 
mouse Inpp5k cDNA was used as a radiolabeled probe. For genotyping, PCR was 
used to amplify a DNA fragment of eGFP or Inpp5k cDNAs present in the transgene 
(see Suppl. Table 1 for primer sequences).              
Renal salt and water handling protocols: Experiments were conducted on age- 
and gender-matched mice. Water handling at baseline and during various protocols 
was assessed in individual metabolic cages, after appropriate training, as described 
[1, 5]. Plasma samples and 24-h urine collections were obtained at baseline, and 
urinary concentrating ability was tested after 24-h water deprivation. The capacity to 
excrete a water load was tested after i.p. injection of 2 ml of sterile water; urine was 
collected under a plastic-wrapped container on an hourly basis for the next 6 hours 
as described [1]. The acute response to vasopressin was investigated by treating 
mice with an i.p. injection of 1ng/g body weight of dDAVP (desmopressin) (Minirin®, 
Ferring, Switzeland) in 100 µl of saline i.p. and collection of urine 5h later to measure 
osmolality.  
Plasma and urine analyses: Plasma urea, glucose and creatinine were measured 
after appropriate sample dilution with a Synchron CX5 Analyzer (Beckman Coulter), 
and osmolality was measured using a Fiske Osmometer (Needham Heights, MA), as 
described [1, 5].    
Histology and immunohistochemistry: Kidney samples were fixed in 4% 
paraformaldehyde (Boehringer Ingelheim, Heidelberg, Germany) in 0.1% mol/l 
phosphate buffer (pH 7.4) before embedding in paraffin, and processed for staining 
and antibodies incubation as described [1]. Sections were viewed under a Zeiss 
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LSM510Meta Confocal microscope (Zeiss, Belgium). Fluorescence measurements 
were performed with a x63/1.4 Plan-Apochromat oil-immersion objective (Zeiss). 
mCCD cell culture, transfection, immunostaining, response to vasopressin and 
fluid transport measurement: mCCD cells were cultured on collagen-coated PTFE 
filter membranes as described [14]. At 60 – 80% confluency, mCCD cells were 
transfected or not with a pWPXLd plasmid expressing either the wild type or the 
catalytically-inactive Inpp5k protein by the use of Fugene HD (Roche). The 
catalytically inactive 42 kDa mouse Inpp5k protein was obtained after mutation of the 
wild type Inpp5k cDNA, according to Communi and Wada [11, 38]: the P283, D287 and 
R288 of the catalytic domain of the Inpp5k protein were respectively mutated in A, A 
and G. Six to ten-day old confluent monolayer cells were used in the experiments. 
For immunostaining, cells were fixed, permeabilized and incubated with a goat anti-
rabbit AQP2 and a monoclonal anti-Flag® antibodies coupled with Alexa633 and 
FITC, respectively. Nuclei were stained with DAPI. Cells were analyzed with a Zeiss 
LSM510Meta Confocal microscope (Zeiss, Belgium). The response to vasopressin 
was tested by treating the filter-seeded cells (transfected or not, as described above) 
with 10nM dDAVP (Sigma) for 5min in the presence of 1mM 3-isobutyl-1-
methylxanthine (IBMX, Sigma). After treatment, cells were washed, incubated with 
sample diluent for 10min at room temperature and centrifuged at 600g at 4°C for 
15min. Fifty µl of the supernatant were used to assay cAMP, using a direct cAMP 
enzyme immunoassay kit (Arbor Assays, Ann Arbor, USA) according to the 
Manufacturer's instructions. Data are based on three independent experiments 
performed in duplicate. 
Cellular fluid transport: Fluid transport was determined in confluent monolayers of 
mCCD cells at day 10 as described previously [15]. For baseline volume 
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measurement, cell culture medium was changed and replaced with fixed volume of 
media introduced in apical and basolateral sides. After an incubation time of 2h or 
15h, the apical and basolateral medium were collected and measured on a precision 
balance. For the effect of an osmotic gradient on fluid transport, a fixed volume of 
diluted culture medium (2/5) was added to the apical side, while undiluted (5/5) 
culture medium was added to the basolateral side. After 2h, both apical and 
basolateral volumes were collected and measured. HgCl2 (1mM), the aquaporins 
inhibitor, was added to the apical side in the presence of a concentration gradient 
(2/5 apical and 5/5 basolateral). After 2h, apical and basolateral volumes were 
collected and measured. Protein levels from each cell culture were determined with a 
BCA kit (Pierce), and were found similar in all conditions. 
Nephron segments microdissection: Eight week-old C57Bl/6 mice were used for 
microdissection of individual nephron segments. Briefly, thin coronal kidney slices 
were prepared, after which cortex and medulla were separated and digested with 
collagenase type II (1mg/ml) for 30 min (for proximal tubules) or 1h (for other tubules) 
at 37°C. Then, tubule suspension was washed and placed on a stage of an inverted 
microscope. A total of 50 proximal tubules (S1S2 and S3), thick ascending limbs of 
Henle’s loop (TAL), and collecting ducts (CD) were collected and placed in 300µl 
RLT-buffer (Qiagen). Total RNA was extracted immediately after microdissection 
using the RNAeasy Micro kit (Qiagen).  
Statistics: All values are expressed as means  standard error of the mean (SEM). 
Significance of differences between two means was calculated using the GraphPad 
InStat software (GraphPad Software, San Diego, USA). Significance level of the 
differences of the means (p-value) is indicated in the legend of each figure. 
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Results: 
Production and characterization of Inpp5k transgenic mice: 
In order to study the role of mouse Inpp5k phosphatase in vivo, a transgenic mouse 
expressing a Flag-tagged 42 kDa Inpp5k protein was generated by infection of 
embryos with a recombinant lentivirus. Since our preliminary results indicated that 
Inpp5k expression is ubiquitous in mouse (Suppl. informations and Suppl. Figure 1), 
a transgene was constructed containing the chicken β actin promoter/enhancer and 
the cytomegalovirus immediate-early enhancer (altogether referred as the CAGG 
promoter) which are known to direct expression of the transgene in many tissues in 
genetically-modified mouse (Figure 1). Downstream of the CAGG promoter, the 
transgene contained a β globin intron, the GFP cDNA flanked by loxP sites, and the 
octapeptide Flag-tagged mouse Inpp5k cDNA. The transgene was inserted into the 
pWPXLd lentiviral plasmid and successfully tested for mutually exclusive expression 
of GFP or Inpp5k proteins in 293 cells (Suppl. informations and Suppl. Figure 2). 
Mouse embryos were infected with lentiviral particles and reimplanted in 
pseudogestant females. The presence of founders in the progeny was checked at 
birth by tail fluorescence analysis and confirmed by PCR analysis. Out of 21 
newborns, two were fluorescent and both transmitted the transgene to their progeny 
(data not shown). Experiments were done to demonstrate that both lentiviral 
transgenic lines A and B had sole transgene integration in the genome, produced the 
Inpp5k transgene only after Cre recombination, and that the transgenic Inpp5k 
protein was ubiquitously expressed and catalytically active in both lines (Suppl. 
informations, Suppl. Figure 3 and data not shown). We also confirmed that both 
PtdIns(4,5)P2 and PtdIns(3,4,5)P3 are substrates for the murine Inpp5k protein 
(Suppl. informations and Suppl. Figure 3). Given the higher amount of Inpp5k protein 
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and 5-phosphatase activity detected in tissues of transgenic line B, this line was used 
in the following experiments. Age-matched non transgenic littermates and transgenic 
line B mice expressing the GFP protein served as controls. As no significant 
difference was observed between both groups of control mice, a potential effect of 
the transgene integration site on the observed phenotype was discarded, and these 2 
groups were finally pooled. 
Altered osmoregulation in Inpp5k transgenic mice: 
Inpp5k transgenic mice were fertile and had a normal life span and general 
behaviour. No evident macroscopic nor microscopic alterations were detected in all 
tissues examined (data not shown). As Inpp5k mRNA and protein have been 
reported to be highly expressed in the kidney [19], renal function and osmoregulation 
parameters at baseline were investigated. Control and Inpp5k transgenic mice were 
similar in terms of body weight, water intake, urinary flow rate and renal function 
(plasma urea and creatinine) (Suppl. Table 2). However, transgenic Inpp5k mice had 
a significantly lower plasma osmolality than control mice (350 ± 3.7 and 335 ± 4.3 
mosmol/kg H2O in control and transgenic mice, respectively; P<0.03, 5 to 6 mice per 
group). These data suggested an abnormal osmoregulation in Inpp5k transgenic 
mice and led us to analyze the renal expression of endogenous and transgenic 
Inpp5k as well as water handling by the kidney in these mice. 
Inpp5k expression in control and Inpp5k transgenic mice: 
Endogenous Inpp5k mRNA expression was investigated by RT-PCR in the different 
nephron segments of wild-type kidneys: endogenous Inpp5k mRNA was found in all 
segments, with the highest expression in the proximal tubule segments (Figure 2a 
and b). The presence of the 44 kDa Flag-tagged Inpp5k transgenic protein was 
identified in both cortical and medullary fractions of Inpp5k transgenic kidneys (Figure 
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2c). As expected, total Inpp5k protein expression was increased in transgenic 
kidneys, as compared to control kidneys. Kidney sections from control and Inpp5k 
transgenic mice were stained for total and transgenic Inpp5k proteins with an anti-
Inpp5k and an anti-Flag antibody, respectively, and analyzed at the confocal 
microscope (Figure 3a). The Flag-tagged transgenic Inpp5k protein was detected in 
the proximal tubules and the medullary collecting ducts of transgenic kidneys, but not 
in control kidneys, as expected. As compared with endogenous Inpp5k expression in 
control kidneys, total Inpp5k protein expression was increased in transgenic kidneys. 
Cellular co-localization of the Flag-tagged Inpp5k transgenic protein with megalin (a 
proximal tubule marker) and AQP2 (a collecting duct marker) confirmed the 
expression of the transgenic Inpp5k protein in these specific nephron segments 
(Figure 3b). Interestingly, the expression of AQP2 was distinctly upregulated in the 
medullary collecting ducts of Inpp5k transgenic kidneys, whereas megalin and 
NKCC2 (a thick ascending limb of Henle’s loop marker) were found unchanged, as 
compared with control kidneys (Figure 3b and data not shown).   
Abnormal water handling in Inpp5k transgenic mice: 
The altered plasma osmolality associated with the expression of the transgenic 
Inpp5k protein in specific nephron segments known to control water and/or ions 
transport suggested abnormal osmoregulation in Inpp5k transgenic mice. In order to 
substantiate this defect, we first tested the urinary concentrating ability of Inpp5k 
transgenic mice following a water deprivation test. The water deprivation resulted in a 
similar weight loss in control and Inpp5k transgenic mice (averaging 14 ± 0.4% in 
control mice and 13 ± 0.8% in Inpp5k transgenic mice, n = 5 pairs) and, as expected, 
a significant reduction in the urine volume (Suppl. Figure 4). These changes were 
similar in both groups of mice, indicating that the mechanisms of solute accumulation 
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in the medulla (i.e. transport of Na+ and urea) allowing a maximal urinary 
concentration were not affected by Inpp5k overexpression. The latter hypothesis was 
also supported by the similar response of the control and Inpp5k transgenic mice to 
the loop diuretic furosemide (data not shown). 
We next evaluated the capacity of the transgenic kidney to eliminate a water load by 
diluting urine (Figure 4a). As compared with control mice, Inpp5k transgenic mice 
showed a significant delay in their ability to excrete the water load, pointing to a 
defective handling of water in the collecting duct. The acute response to vasopressin 
was also investigated in these mice, revealing that the maximal urine osmolality was 
significantly higher in Inpp5k transgenic mice as compared with controls (3815 ± 100 
vs. 2561 ± 254 mOsm/kg H20, P < 0.005)(Figure 4b). Together, the lower plasma 
osmolality, impaired ability to excrete a water load and increased response to dDAVP 
indicated that Inpp5k transgenic mice had a significant defect in osmoregulation, 
which could be related to a specific effect of Inpp5k on the vasopressin/AQP2 axis in 
the kidneys.  
Abnormal arginine vasopressin (AVP) signalling pathway in Inpp5k transgenic 
mice:  
In order to investigate the mechanism of altered water handling in Inpp5k transgenic 
mice, real time RT-PCR was first used to test for the differential expression of 
transcripts that are primarily involved in the AVP signalling pathway, including 
AVPR2 receptor and AQP2 in the kidney, and AVP in the brain (Figure 4c). The 
expression of AVPR2 and AQP2 mRNA were significantly increased in the kidneys of 
the Inpp5k transgenic mice as compared with controls. By contrast, the kidney 
expression of transcripts corresponding to pathways involved in Na+ or K+ handling 
(e.g. Na+/K+-ATPase and the different ENaC subunits) was unchanged (Figure 4b). 
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In the brain, AVP mRNA expression was found significantly decreased in Inpp5k 
transgenic mice, as expected from a feedback response of the lower plasma 
osmolality values (Figure 4c). We next investigated AQP2 protein expression and 
phosphorylation in transgenic kidneys by Western blotting (Figure 4d and 4e). 
Immunoblot analyses essentially confirmed the immunostaining results presented in 
Figure 3b: a significant overexpression of AQP2 protein was detected in the 
transgenic kidney as compared with control kidney. The proportion of phosphorylated 
AQP2 protein was also significantly increased in Inpp5k transgenic kidney (Figure 
4e). 
Together, these results indicate that the osmoregulation defect detected in Inpp5k 
transgenic mice is caused by alteration in the AVPR2/AQP2 signalling pathway in 
kidney collecting ducts.  
AQP2 and AVPR2 expression, cAMP production and water transport in mouse 
collecting duct cells overexpressing Inpp5k: 
The mouse CCD (mCCD) cells represent a well established model to investigate the 
mechanisms of water reabsorption in the collecting duct. In order to confirm and 
substantiate the link between Inpp5k overexpression and the water handling defect 
observed in mice, mCCDcells were plated on filters and transfected or not with either 
a catalytically active or inactive Inpp5k expression vector. The cells were then 
cultured to confluency to develop a polarized monolayer. Transfection of mCCD cells 
with wild type Inpp5k resulted in higher AQP2 protein expression and plasma 
membrane localization than in non-transfected cells (Figure 5a-c). An intact Inpp5k 
enzymatic activity was required to observe the AQP2 expression and localization 
defects, since transfection of mCCD cells with a catalytically-inactive Inpp5k protein 
had no effect (Figure 5). Further studies demonstrated that cells transfected with 
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wild-type Inpp5k had a significantly higher mRNA expression of AVPR2 (Figure 5d), 
which was reflected by a significantly (> 2-fold) accentuated cAMP response to 
treatment with dDAVP (Figure 5e). Again, these changes were not observed in cells 
transfected with the catalytically inactive Inpp5k.  
These AQP2 and AVPR2 studies were correlated with measurement of net water 
transport across polarized mCCD cell monolayers (Figure 6). Indeed, two and 15h 
after placing iso-osmotic media on both sides of the mCCD cell monolayer, an 
increased water transport was detected in wild-type Inpp5k-transfected cells, as 
compared with non transfected and catalytically inactive Inpp5k transfected cells. 
When a hypo-osmotic medium was placed at the apical side of the mCCD cell 
monolayer, water transport was increased in all three conditions tested. However, 
water transport was still significantly increased in wild type Inpp5k transfected cells 
(Figure 6). Addition of HgCl2, which blocks AQP2 by interacting with a critical 
cysteine residue in the water pore, nearly completely blocked the osmotically-induced 
water transport in all cells tested (Figure 6). Together, these results indicate that the 
active form of Inpp5k tightly controls AQP2 expression and plasma membrane 
localization, as well as the osmotically-induced water transport in mouse collecting 
duct cells.         
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Discussion: 
We report here that transgenic mice overexpressing the phosphoinositide 5-
phosphatase Inpp5k present an altered water metabolism characterized by a 
decreased plasma osmolality in basal conditions, a decreased ability to excrete a 
water load, and an increased urinary concentrating response to arginin vasopressin. 
These physiological alterations are associated with defects in the AVPR2/AQP2 
signalling pathway in the collecting ducts of the kidney. Indeed, overexpression of 
wild type, but not that of catalytically-inactive Inpp5k in mouse collecting duct cells 
results in an increased water transport associated with increased AVPR2 expression 
and cAMP response to vasopressin, and with increased AQP2 expression and 
plasma membrane localization, providing a mechanism to explain the defects 
observed in Inpp5k transgenic mice. Together, we conclude that Inpp5k as an 
important regulator of the AVPR2/AQP2 signalling pathway and water metabolism.     
Inpp5k is a member of the phosphoinositide 5-phosphatases family with catalytic 
activity directed towards PtdIns(4,5)P2 and PtdIns(3,4,5)P3 [19-21, 37]. Our Northern 
blot, RT-PCR and Western blot analyses have identified mouse Inpp5k as an 
ubiquitously expressed phosphatase.  Several Inpp5k mRNA and protein molecular 
weight forms have been detected in mouse tissues, as in man [19]. In the kidney, 
Inpp5k mRNA is also differentially expressed along the nephron and the collecting 
duct, and 3 molecular forms were identified in the cortex and the medulla. This very 
complex pattern of expression is probably of significant relevance and must serve 
specific physiological function for the Inpp5k enzyme in the different regions of the 
kidney and other tissues.              
Recently, PpsBrdm1 mice with a frameshift mutation in the Inpp5k/Pps coding 
sequence downstream of exon 7 have been generated [21]. The homozygous 
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PpsBrdm1 mutation caused embryonic lethality of unknown origin. In adult 
heterozygous PpsBrdm1/+ mice, a significant increase in insulin sensitivity was 
observed in skeletal muscles, and these mice were also resistant to a high fat diet-
induced obesity. By contrast, no difference was detected between control and 
PpsBrdm1/+ mice for insulin signalling in the adipose tissue and for hepatic glucose 
production following insulin administration. Although our transgenic mice expressed 
high amount of catalytically active Inpp5k in skeletal muscles, no significant 
difference was found in insulin and glucose tolerance tests as compared to control 
mice (data not shown). This negative result is rather surprising, because 
overexpression of Inpp5k in insulin-stimulated CHO cells was reported to inhibit 
phosphoinositide 3-kinase signalling by reducing PtdIns(3,4,5)P3 concentrations and 
downstream signalling [20]. In addition, we expected to observe a frank insulin 
resistance in our transgenic mice which mirrored the increase in insulin sensitivity 
observed in PpsBrdm1/+ mice. The possible reason(s) of this discrepancy between our 
results and those of Takenawa are currently unknown. It could result from the use of 
different Inpp5k molecular weight forms with potentially different function and/or 5-
phosphatase activities to express Inpp5k in our transgenic mice (42 kDa) and in CHO 
cells (approximately 50 kDa). Alternatively, the expression of the catalytically active 
Inpp5k protein in muscles of our transgenic mice is may be not sufficient to 
reproduce the in vitro effects or to mirror the phenotype detected in the PpsBrdm1/+ 
mice. Indeed, the presence of compensatory mechanisms involving other 
phosphoinositide phosphatases expressed in the muscles of our transgenic mice 
cannot be ruled out, similarly to the compensation of the absence of the OCRL 
protein by the 75 kDa protein [23].   
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Arginine vasopressin, AVPR2 and AQP2 are key components in the signalling 
pathway involved in the control of the final urine concentration by the principal cells 
lining the collecting ducts. Under basal conditions, AQP2-containing vesicles are 
maintained in the subapical region of the cells. When the organism is exposed to a 
loss of free water, plasma osmolality increases, stimulating the release of AVP by the 
posterior pituitary into the circulation. In turn, AVP binds to the AVPR2 on principal 
cells, leading to increased cAMP levels stimulating the expression of AQP2 as well 
as the phosphorylation and shuttle of AQP2 from subapical storage vesicles to the 
apical membrane, thereby increasing the osmotically-induced water transport. Our 
data demonstrate that AVPR2, AQP2 and p-AQP2 expression is upregulated in 
Inpp5k transgenic kidneys. The overexperssion of these three factors in collecting 
duct cells would substantiate an increase in water reabsorption and the subsequent 
reduced basal osmolality and delayed ability to excrete a water load. The fact that 
this phenotype results from a primary renal deficit is confirmed by the physiological 
response of the brain, i.e. a decreased AVP mRNA expression secondary to lower 
plasma osmolality. It is noteworthy that the AQP2 mRNA and protein expressions are 
distinctly upregulated in the medullary collecting ducts of Inpp5k transgenic mice, 
whereas markers of other segments (i.e. megalin and NKCC2) are found unchanged.  
Furthermore, our studies in the mCCD cells demonstrate that Inpp5k overexpression 
alone, and not its catalytic mutant, is sufficient to upregulate AVPR2, increasing the 
cAMP response to dDAVP, which could then explain the observed increase in AQP2 
expression and osmotic water transport. Unfortunately, we were unable to investigate 
the effects of a decreased Inpp5k protein expression on the AVP/AQP2 signalling 
pathway in this cellular system, because of the different kinetics of AQP2 expression 
and siRNA-induced Inpp5k downregulation in mCCD cells (data not shown).  
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Interestingly, no proximal tubule phenotype was detected in Inpp5k transgenic mice, 
despite expression of the transgene in this nephron segment. This may be related to 
the fact that the AQP1 water channels expressed in these tubules are constitutively 
inserted in the plasma membrane, without trafficking regulation nor response to AVP.  
The mechanism leading to increased expression of AVPR2 and AQP2 mRNA as well 
as to increased AQP2 plasma membrane localization in collecting duct cells 
overexpressing Inpp5k certainly requires an intact phosphoinositide 5-phosphatase 
activity. Phosphoinositides signalling occurs in many different intracellular 
membranes, including the inner surface of the plasma membrane and the membrane 
vesicles that move to the plasma membrane, providing a potential explanation for the 
increased AQP2 expression at the cell surface of collecting duct cells when 
catalytically active Inpp5k is overexpressed. It is noteworthy that a still poorly defined 
nuclear phosphoinositide signalling pathway, including PtdIns(4,5)P2 signalling, also 
occurs and has been shown to control gene expression, mRNA export as well as 
chromatin remodelling [4, 27]. The overexpression of the inositol Inpp5k 5-
phosphatase in mCCD cells represents thus a new model to understand how 
phosphoinositides enter the nucleus and impact on nuclear processes.    
In conclusion, we have here for the first time identified a role for the inositol 5-
phosphatase Inpp5k in the mouse kidney: Inpp5k controls plasma osmolality via the 
regulation of the AVPR2/AQP-2 signalling pathway and of water transport in kidney 
collecting duct cells. Although the role of Inpp5k in the human kidney has not been 
investigated, our data suggest that Inpp5k could be important in patients with 
inappropriate water handling by the collecting duct. 
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Figure Legends: 
Figure 1: Inpp5k transgene structure. Transgene structure before (a) and after (b) 
Cre recombination showing the CAGG promoter (including the CMV enhancer), the β 
globin intron, a first loxP site, the enhanced green fluorescent protein (GFP) cDNA, a 
second loxP site, and the Flag-tagged mouse Inpp5k cDNA. A viral LTR is present at 
both transgene extremities.  
Figure 2: Inpp5k expression in the kidney of control and Inpp5k transgenic 
mice. (a) and (b) Comparative expression of endogenous Inpp5k mRNA in different 
nephron segments from wild-type kidney. The expression level of Inpp5k was 
analyzed by quantitative RT-PCR. Nephron segments are characterized by the 
enrichment for respective markers (b): podocin for glomeruli (Gl), AQP-1 for the 
S1S2 and S3 segments of the proximal tubule, NKCC2 for the thick ascending limb 
(TAL) and AQP-2 for the collecting duct (CD). (c) Representative immunoblot on 
cortical and medullary fractions of wild-type (ctrl) and Inpp5k transgenic (Tg) mice. 
Cytosolic proteins (20 µg) were separated by SDS-PAGE and blotted onto 
nitrocellulose membrane, before incubation with anti-Inpp5k (1/1000) or anti-Flag 
(1/1000) affinity-purified antibodies. Loading control was performed after membrane 
stripping and incubation with monoclonal anti-β-actin antibody (1/10 000).  
Figure 3: Inpp5k immunostaining on kidney sections from control and Inpp5k 
transgenic mice. Control and Inpp5k transgenic (Tg) kidneys were stained with (a) 
anti-Inpp5k (1/200) and anti-Flag (1/100) antibodies, and with (b) anti-megalin 
(1/10000), anti-AQP2 (1/200) and anti-Flag (1/100) antibodies. The transgenic Inpp5k 
protein is located in the proximal tubules (cytoplasmic pattern, with expression of 
megalin in the apical membrane) and in the medullary collecting ducts (co-expression 
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with AQP2, which is distinctly upregulated in these profiles). Total Inpp5k expression 
and AQP2 expression are increased in Inpp5k transgenic kidneys. Bar: 10µm. 
Figure 4: Abnormal water handling, acute response to vasopressin and renal 
AQP2 expression in Inpp5k transgenic mice: (a) The urine output was analyzed in 
control (white bars) and Inpp5k transgenic (black bars) mice during 4 h in a test of 
acute water loading (2 ml intraperitoneally). Results are means ± SEM of 6 pairs of 5-
month old male mice and are expressed as ml of urine excreted over the last 1h 
interval. Statistics: *: P<0.05. (b) Effect of dDAVP treatment on urine osmolality in 
control and Inpp5k transgenic mice. After adaptation and baseline collection, mice 
were treated with 1ng/g body weight of dDAVP (MinirinR) and urine was collected 5h 
later to measure osmolality (Uosmo). The two groups of mice show similar urine 
osmolality values at baseline, whereas treatment with dDAVP induces a significantly 
higher response in the Inpp5k transgenic mice vs. controls. Data were obtained on 4 
pairs of control vs. transgenic Inpp5k mice. Statistics: **: P<0.005. (c) Real time RT-
PCR quantification of mRNA expression in the kidney and the brain. Messenger RNA 
levels were first adjusted to glyceraldehydes-3-phosphate deshydrogenase 
(GAPDH), then normalized to the control mice level set at 100% using the following 
formula: Ratio = 2∆Ct(GAPDH – target Inpp5k transgenic mice) - ∆Ct(GAPDH – target control mice). The 
normalized values (mean ± SEM) are shown on the right of the panel. Eight pairs of 
kidney and brain from 5-month old male mice were analyzed. Statistics: *: P<0.05. 
(d) Western blot analysis of AQP2, phosphorylated AQP2 (p-AQP2) and actin (as a 
loading control) in kidney extracts from control (C) and Inpp5k transgenic mice 
(Inpp5k). Five pairs of kidney from 5-month old male mice were analyzed. (e) 
Densitometry analyses (core and glycosylated bands) confirm that there is a 
significant increase of both AQP2 and p-AQP2 proteins in the kidney extracts from 
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Inpp5k transgenic (black bars) mice, as compared with control (white bars) mice. 
Results are means ± SEM and are expressed as a ratio between AQP2 or p-AQP2 
signals and actin signal. Statistics: *: P<0.05; **: P<0.005. 
Figure 5: Increased AQP2 and Avpr2 expression and dDAVP-induced cAMP 
production in Inpp5k-transfected mCCD cells:  
(a) Non transfected, wild type or catalytically inactive Inpp5k-transfected mCCD cells 
were cultured to confluency on filters to obtain a polarized cell monolayer. Anti-AQP2 
(red) and anti-Inpp5k (green) antibodies were incubated with permeabilized cells and 
analyzed by confocal microscopy. (b) Western blot analysis of non transfected and 
wild type or catalytically-inactive Inpp5k-transfected mCCD cell protein extracts with 
an anti-AQP2 antibody. Actin served as loading control. (c) Plasma membrane of 10-
day old confluent mCCD cells under control conditions (c) or after transfection with 
either wild type Inpp5k (In) or catalytically-inactive Inpp5k (inIn) were obtained after 
biotinylation assay. Plasma membrane and cytosol fraction were analysed by 
Western blotting with an anti-AQP2 antibody. Equal amounts of protein (20 µg/lane) 
were charged. (d) Increased expression of Avpr2 in Inpp5k-transfected mCCD cells.  
Quantification (real-time PCR) of target mRNA in mCCD, expressed as relative 
expression over non tranfected cells (n=4). Significant differences (*** p<0.001) 
between different conditions are indicated. (e) Effects of dDAVP (10nM) on cAMP 
production in mCCD cells transfected with Mock or inactive Inpp5k or Inpp5k 
plasmid. mCCD grown on filter membranes were pretreated with 1mM 3-isobutyl-1-
methylxanthine (IBMX) for 10min. Where indicated (+), cells were stimulated with 
10nM of dDAVP for 5min in the continuous presence of IBMX. Cells were lysed and 
subjected to cAMP measurements. The mean cAMP concentration (cAMP+/- SEM  
(in pmol/ml)) was determined from three independent experiments performed in 
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duplicate (6 filters per condition). Significant differences (* p<0,05; ** p<0.01; *** 
p<0.001) between different conditions are indicated. Data are mean ± SEM.  
Figure 6: Increased water transport in Inpp5k transfected mCCD cells: Non 
transfected and wild type or catalytically inactive Inpp5k transfected mCCD cell 
monolayer were incubated with iso- (baseline) or hypo- (osmotic gradient) osmotic 
medium at the apical side. After 2 and 15h, medium volumes at the apical and 
basolateral sides of the cell monolayer were measured and the net water transport 
calculated. The aquaporins inhibitor HgCl2 (1 mM) was added to the medium at the 
apical side of the cell monolayer. For each condition, results are representative of 6 
independent experiments performed in triplicate. Mean ± SEM are represented. 
Statistics: *: P<0.001when comparing wild type Inpp5k-transfected cells with either 
non-transfected or catalytically inactive Inpp5k-transfected cells.   
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 Supplementary Table 2: Baseline parameters, renal function and water 
metabolism in Inpp5k transgenic mice 
Parameter Control mice Inpp5k transgenic 
mice 
P 
Body weight (g) 31.0 ± 0.6 (16) 31.1 ± 0.5 (15) 0.99 
Water Intake (ml/24h) 4.8 ± 0.6 (16) 4.0 ± 0.5 (15) 0.37 
Urine volume (µl/24h) 1813 ± 130 (16) 1617 ± 180 (15) 0.38 
Plasma Urea (mg/dl) 53.0 ± 1.5 (5) 56.0 ± 2.4 (6) 0.33 
Plasma Creatinine 
(mg/dl) 
0.098 ± 0.007 (5) 0.098 ± 0.008 (6) 0.98 
 
Data are means ± SEM. Numbers in parentheses refer to number of mice.  
          .      
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Supplementary information: 
Inpp5k expression in mouse tissues and cells: 
Tissue distribution of the mouse Inpp5k mRNA was investigated by Northern blotting 
and RT-PCR. As previously reported for human Inpp5k, 2 different transcripts of 
about 3.0 and 2.2 kb were detected in nearly all tissues tested (Suppl. Figure 1a). A 
very strong signal was observed in the testis, where an additional 2.4 kb transcript 
was detected. Expression was particularly important in eye and kidney, and nearly 
undetectable in the liver. RT-PCR performed on the same mRNA preparations 
confirmed the Northern blot results (data not shown). Inpp5k mRNA was also 
detected by PCR in cDNA preparations from hematopoïetic cells, including resting 
and activated purified T and B lymphocytes, macrophages and neutrophils, as well 
as mature and immature dendritic cells, eosinophils and mast cells (Suppl. Figure 1B 
and data not shown). Next, tissue protein extracts were probed by Western blotting 
with an immunizing peptide affinity-purified rabbit antibody raised against the C-
terminal 16 amino acids of the Inpp5k mouse protein. A total of four molecular weight 
forms were detected. In most of the tissues analyzed, polypeptides of 54 kDa and/or 
42 kDa were clearly detected. Expression was very significant in testis, eye and 
spleen, and nearly undetectable in muscle and heart (Suppl. Figure 1C). However, 
prolonged exposure of the membrane confirmed the presence of a 42 kDa 
polypeptide in the two latter tissues (data not shown). A third 51 kDa immunoreactive 
signal was specifically observed in testis and brain. Finally, in the kidney, a 36 kDa 
polypeptide was also expressed in addition to the 42 kDa polypeptide (Suppl. Figure 
1C). No signal was observed in Western blotting when the Inpp5k antibody was 
preincubated with the immunogenic peptide (data not shown).  
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GFP and Inpp5k proteins expression after pWPXLd lentiviral plasmid 
transfection in 293 cells: 
293 cells were transfected either with the pWPXLd/GFP/Inpp5k plasmid containing 
both GFP and Inpp5k cDNAs, or with the pWPXLd/Inpp5k plasmid obtained after Cre 
recombination. As expected, cells transfected with the pWPXLd/GFP/Inpp5k plasmid 
were fluorescent but did not express the mouse Inpp5k protein, while 
pWPXLd/Inpp5k-transfected cells were not fluorescent but did express a 44 kDa 
Flag-tagged Inpp5k protein (Suppl. Figure 2). 
Characterization of GFP- and Inpp5k-transgenic mouse lines:  
Southern blot analysis using several restriction enzymes and a radiolabeled mouse 
Inpp5k cDNA probe revealed that, as compared to non transgenic control DNA, DNA 
extracted from both transgenic lines had an extra signal which corresponded to a 
unique transgene integration site in the genome (data not shown). In order to remove 
the GFP cDNA out of the genome and to induce the expression of the Flag-tagged 
Inpp5k protein, males from both lines were crossed with female PGK-Cre mice which 
express the Cre recombinase in all tissues early during embryogenesis. 
Immunoprecipitation followed by Western blotting revealed that no transgenic Inpp5k 
protein was expressed in the heart of GFP mice before Cre recombination, and that 
Cre recombination induced the production of a 44 kDa Flag-tagged Inpp5k protein 
only in Inpp5k mice (Suppl. Figure 3a). Similar results were obtained on kidney 
protein extracts (data not shown). Western blot analysis of the 44 kDa Flag-tagged 
transgenic Inpp5k protein in multiple tissues showed that the expression was rather 
ubiquitous (Suppl. Figure 3b). Finally, PtdIns(4,5)P2 and PtdIns(3,4,5)P3 
phosphatase activities were analyzed in kidney protein extracts from non transgenic 
control and Inpp5k transgenic lines (Suppl. Figure 3c). Phosphatase activity was 
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significantly detected in the total kidney protein extracts from both Inpp5k transgenic 
lines after immunoprecipitation with the anti-Flag antibody. These data reflect thus 
the phosphoinositide phosphatase activity of the transgenic Inpp5k protein only. As 
expected, no significant phosphate release was detected in non transgenic control 
mice (Suppl. Figure 3c). In the anti-Inpp5k immunoprecipitates, phosphatase activity 
was detected with both substrates in non transgenic control mice, indicating the 
presence of the endogeneous Inpp5k protein. However, in both Inpp5k transgenic 
lines, activity measured with the two substrates was higher than in control mice, 
reaching significantly higher levels in transgenic line B kidney extracts (Suppl. Figure 
3c). Preincubation of the anti-Inpp5k antibody with the immunogenic peptide before 
immunoprecipitation nearly completely prevented phosphatase activity from kidney 
extracts (data not shown).  
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Supplementary Figure Legends: 
Supplementary Figure 1: Inpp5k mRNA and protein expression in mouse 
tissues and cells. (a, b) Inpp5k mRNA expression was analyzed by Northern blot in 
adult C57BL/6 mouse tissues using a Inpp5k cDNA probe (a), and by RT-PCR in 
purified mouse hematopoïetic cells (b). T: thymus; B: brain; E: eye; H: heart; L: liver; 
AG: adrenal gland; K: kidney; Te: testis; O: ovary; AT: adipose tissue; TL: T 
lymphocyte; BL: B lymphocyte; M: macrophage; N: neutrophil; mDC and iDC: mature 
and immature dendritic cells. (-) and (+) represent resting and activated cells. C- and 
C+ are negative and positive controls for RT-PCR. Hprt: a cDNA probe encoding for 
hypoxanthine-guanine phosphoribosyltranferase served as loading control (c) Inpp5k 
protein expression was analyzed by Western blotting using an affinity-purified rabbit 
polyclonal anti-mouse Inpp5k antibody. An anti-actin antibody served as loading 
control. E: eye; H: heart; B: brain; Lu: lung; I: intestine; S: spleen; K: kidney; Te: 
testis; SM: skeletal muscle; O: ovary.          
Supplementary Figure 2: Characterization of lentiviral vectors used for 
transgenic mouse production. Mutually exclusive expression of GFP and Flag-
tagged Inpp5k proteins in 293 cells after transfection with either the 
pWPXLd/GFP/Inpp5k plasmid, or the pWPXLd/Inpp5k plasmid obtained after Cre 
recombination. Fluorescence analysis (left and middle panels) and Western blot 
analysis using an anti-Flag antibody (right panel). NT: not transfected. 
Supplementary Figure 3: Characterization of Inpp5k transgenic mice: (a) Cre 
recombination induces the expression of the transgenic Inpp5k protein. Western blot 
analysis with an anti-Flag tag antibody shows that Inpp5k transgenic mice produce 
the Flag-tagged Inpp5k protein (44 kDa) in the heart. No signal is detected in GFP 
transgenic mice before Cre recombination nor in non transgenic control (C) mice. (b) 
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Expression of the Flag-tagged transgenic Inpp5k protein in tissues from Inpp5k 
transgenic mice by Western blotting. Loading control was checked with an anti-actin 
antibody. E: eye; T: thymus; H: heart; Lu: lung; L: liver; S: spleen; I: intestine; K: 
kidney; LN: lymph node; B: brain; Te: testis. (c) PtdIns(4,5)P2 and PtdIns(3,4,5)P3 5-
phosphatase activities in anti-Flag or anti-Inpp5k immunoprecipitates from total 
kidney protein extracts isolated from transgenic lines A (LA) and B (LB), as well as 
from non transgenic control mice (C). Results are means ± SEM of 3 separate 
experiments. IP: immunoprecipitate. Statistics, as compared with non transgenic 
control mice: *: P<0.05; **: P<0.01; ***: P<0.005. 
Supplementary Figure 4: Water deprivation test: Urine output was measured 
during a 24-h baseline (white columns) and a 24-h water deprivation (black columns) 
period in control (C) and Inpp5k transgenic (Inpp5k) mice. Results are means ± SEM 
of 5 pairs of 4-month old male mice and are expressed in µl of urine output per 
minute and per g of body weight.  
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Figure 1: Inpp5k transgene structure Transgene structure before (a) and after (b)   .       
Cre recombination showing the CAGG promoter (including the CMV enhancer), the β 
globin intron, a first loxP site, the enhanced green fluorescent protein (GFP) cDNA, a 
second loxP site, and the Flag-tagged mouse Inpp5k cDNA. A viral LTR is present at 
both transgene extremities.
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Figure 2: Inpp5k expression in the kidney of control and Inpp5k transgenic mice. (a) 
and (b) Comparati e e pression of endogeno s Inpp5k mRNA in different nephron  v  x   u      
segments from wild-type kidney. The expression level of Inpp5k was analyzed by 
quantitative RT-PCR. (b) Nephron segments are characterized by the enrichment for 
respective markers: podocin for glomeruli (Gl), AQP-1 for the S1S2 and S3 segments of 
the proximal tubule, NKCC2 for the thick ascending limb (TAL) and AQP-2 for the 
collecting duct (CD). (c) Representative immunoblot on cortical and medullary fractions of 
wild-type (ctrl) and Inpp5k transgenic (Tg) mice. Cytosolic proteins (20 µg) were separated 
by SDS PAGE and blotted onto nitrocellulose membrane before incubation with anti -      ,    -
Inpp5k (1/1000) or anti-Flag (1/1000) affinity-purified antibodies. Loading control was 
performed after membrane stripping and incubation with monoclonal antibodies anti-β-
actin (1/10 000). 
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Figure 3: Inpp5k immunostaining on kidney sections from control and Inpp5k 
transgenic mice Control and Inpp5k transgenic (Tg) kidne s ere stained ith (a) anti .      y  w   w   -
Inpp5k (1/200) and anti-Flag (1/100) antibodies, and with (b) anti-megalin (1/10000), anti-
AQP2 (1/200) and anti-Flag (1/100) antibodies. The transgenic Inpp5k protein is located in 
the proximal tubules (cytoplasmic pattern, with expression of megalin in the apical 
membrane) and in the medullary collecting ducts (co-expression with AQP2, which is 
distinctly upregulated in these profiles). Total Inpp5k expression and AQP2 expression are 
increased in Inpp5k transgenic kidneys. Bar: 10µm.
a 1a s
t
  * * 4000
**
b
0
0,5
r
i
n
e
 
o
u
t
p
u
t
 
(
m
l
/
l
a
1
‐
h
 
i
n
t
e
r
v
a
l
1000
2000
3000 Baseline
Minirin
U
o
s
m
o
d C Inpp5k
1 2 3 4
Hours after water load
U
c
0
Control Inpp5k
AQP‐2
‐ 28
kDa
‐ 35
‐ 50
AQP‐2
AVPR2
AQP‐3
NaK ATPase
ENaC alpha
ENaC beta
*
*
p‐AQP‐2
actin
‐ 28
‐ 45
‐ 35
‐ 50
0 50 100 1500 50 100 150
 
ENaC gamma
Brain AVP *
e 3 *
e
1
2
**
O
p
t
i
c
a
l
 
d
e
n
s
i
t
y
/
a
c
t
i
n
e
0
AQP‐2 p‐AQP‐2
Figure 4: Abnormal water handling, acute response to vasopressin and renal AQP2 expression in 
Inpp5k transgenic mice: (a) The urine output was analyzed in control (white bars) and Inpp5k 
transgenic (black bars) mice during 4 h in a test of acute water loading (2 ml intraperitoneally). 
Results are means ± SEM of 6 pairs of 5‐month old male mice and are expressed as ml of urine 
excreted over the last 1h interval Statistics: *: P<0 05 (b) Effect of dDAVP treatment on urine          .      . .             
osmolality in control and Inpp5k transgenic mice. After adaptation and baseline collection, mice 
were treated with 1ng/g body weight of dDAVP (MinirinR) and urine was collected 5h later to 
measure osmolality (Uosmo). The two groups of mice show similar urine osmolality values at 
baseline, whereas treatment with dDAVP induces a significantly higher response in the Inpp5k 
transgenic mice vs. controls. Data were obtained on 4 pairs of control vs. transgenic Inpp5k mice. 
Statistics: **: P<0.005. (c) Real time RT‐PCR quantification of mRNA expression in the kidney and 
the brain Messenger RNA levels were first adjusted to glyceraldehydes‐3‐phosphate  .                 
deshydrogenase (GAPDH), then normalized to the control mice level set at 100% using the 
following formula: Ratio = 2∆Ct(GAPDH – target Inpp5k transgenic mice) ‐ ∆Ct(GAPDH – target control mice). The normalized 
values (mean ± SEM) are shown on the right of the panel. Eight pairs of kidney and brain from 5‐
month old male mice were analyzed. Statistics: *: P<0.05. (d) Western blot analysis of AQP2, 
phosphorylated AQP2 (p‐AQP2) and actin (as a loading control) in kidney extracts from control (C) 
and Inpp5k transgenic mice (Inpp5k). Five pairs of kidney from 5‐month old male mice were 
analyzed (e) Densitometry analyses (core and glycosylated bands) confirm that there is a.                       
significant increase of both AQP2 and p‐AQP2 proteins in the kidney extracts from Inpp5k 
transgenic (black bars) mice, as compared with control (white bars) mice. Results are means ± SEM 
and are expressed as a ratio between AQP2 or p‐AQP2 signals and actin signal. Statistics: *: P<0.05; 
**: P<0.005.
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Figure 5: Increased AQP2 and Avpr2 expression and dDAVP‐induced cAMP production in Inpp5k‐
transfected mCCD cells:   
(a) Non transfected, wild type or catalytically inactive Inpp5k‐transfected mCCD cells were cultured to 
confluency on filters to obtain a polarized cell monolayer. Anti‐AQP2 (red) and anti‐Inpp5k (green) 
antibodies were incubated with permeabilized cells and analyzed by confocal microscopy. (b) Western 
blot analysis of non transfected and wild type or catalytically‐inactive Inpp5k‐transfected mCCD cell 
protein extracts with an anti‐AQP2 antibody. Actin served as loading control. (c) Plasma membrane of 
10‐day old confluent mCCD cells under control conditions (c) or after transfection with either wild type 
Inpp5k (In) or catalytically‐inactive Inpp5k (inIn) were obtained after biotinylation assay. Plasma                     
membrane and cytosol fraction were analysed by Western blotting with an anti‐AQP2 antibody. Equal 
amounts of protein (20 µg/lane) were charged. (d) Increased expression of Avpr2 in Inpp5k‐
transfected mCCD cells. 
f ( l ) f d lQuanti ication  rea ‐time PCR  o  target mRNA in mCCD, expresse  as re ative expression over non 
tranfected cells (n=4). Significant differences (*** p<0.001) between different conditions are indicated. 
(e) Effects of dDAVP (10nM) on cAMP production in mCCD cells transfected with Mock or inactive 
Inpp5k or Inpp5k plasmid. mCCD grown on filter membranes were pretreated with 1mM 3‐isobutyl‐1‐                       
methylxanthine (IBMX) for 10min. Where indicated (+), cells were stimulated with 10nM of dDAVP for 
5min in the continuous presence of IBMX. Cells were lysed and subjected to cAMP measurements. The 
mean cAMP concentration (cAMP+/‐ SEM  (in pmol/ml)) was determined from three independent 
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p<0.01; *** p<0.001) between different conditions are indicated. Data are mean ± SEM. 
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Fig re 6 Increased ater transport in Inpp5k transfected mCCD cells Non transfectedu  :  w     :  
and wild type or catalytically inactive Inpp5k transfected mCCD cell monolayer were incubated 
with iso- (baseline) or hypo- (osmotic gradient) osmotic medium at the apical side. After 2 and 
15h, medium volumes at the apical and basolateral sides of the cell monolayer were 
measured and the net water transport calculated. The aquaporins inhibitor HgCl2 (1 mM) was 
added to the medium at the apical side of the cell monolayer. For each condition, results are 
representative of 6 independent experiments performed in triplicate. Mean ± SEM are 
represented Statistics: *: P<0 001when comparing wild type Inpp5k transfected cells with.   .     -    
either non-transfected or catalytically inactive Inpp5k-transfected cells.   
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Supplementary Figure 1: Inpp5k mRNA and protein expression in mouse tissues 
and cells. (a, b) Inpp5k mRNA expression was analyzed by Northern blot in adult 
C57BL/6 mouse tissues using a Inpp5k cDNA probe (a) and by RT PCR in purified       ,   -    
mouse hematopoïetic cells (b). T: thymus; B: brain; E: eye; H: heart; L: liver; AG: adrenal 
gland; K: kidney; Te: testis; O: ovary; AT: adipose tissue; TL: T lymphocyte; BL: B 
lymphocyte; M: macrophage; N: neutrophil; mDC and iDC: mature and immature dendritic
cells. (-) and (+) represent resting and activated cells. C- and C+ are negative and positive 
controls for RT-PCR. Hprt: a cDNA probe encoding for hypoxanthine-guanine 
phosphoribosyltranferase served as loading control (c) Inpp5k protein expression was 
analyzed by Western blotting using an affinity purified rabbit polyclonal anti mouse Inpp5k      -    -   
antibody. An anti-actin antibody served as loading control. E: eye; H: heart; B: brain; Lu: 
lung; I: intestine; S: spleen; K: kidney; Te: testis; SM: skeletal muscle; O: ovary.         
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Supplementary Figure 2: Characterization of lentiviral vectors used for transgenic 
mouse production. Mutually exclusive expression of GFP and Flag-tagged Inpp5k 
proteins in 293 cells after transfection with either the pWPXLd/GFP Inpp5k plasmid or        -  ,  
the pWPXLd/Inpp5k plasmid obtained after Cre recombination. Fluorescence analysis 
(left and middle panels) and Western blot analysis using an anti-Flag antibody (right 
panel). NT: not transfected.
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Supplementary Figure 3: Characterization of Inpp5k transgenic mice: (a) Cre
recombination induces the expression of the transgenic Inpp5k protein. Western blot analysis 
with an anti-Flag tag antibody shows that Inpp5k transgenic mice produce the Flag-tagged             
Inpp5k protein (44 kDa) in the heart. No signal is detected in GFP transgenic mice before Cre
recombination nor in non transgenic control (C) mice. (b) Expression of the Flag-tagged 
transgenic Inpp5k protein in tissues from Inpp5k transgenic mice by Western blotting. 
L di t l h k d ith ti ti tib d E T th H h t Loa ng con ro  was c ec e  w  an an -ac n an o y. : eye; : ymus; : ear ; u: 
lung; L: liver; S: spleen; I: intestine; K: kidney; LN: lymph node; B: brain; Te: testis. (c) 
PtdIns(4,5)P2 and PtdIns(3,4,5)P3 5-phosphatase activities in anti-Flag or anti-Inpp5k 
immunoprecipitates from total kidney protein extracts isolated from transgenic lines A (LA)           
and B (LB), as well as from non transgenic control mice (C). Results are means ± SEM of 3 
separate experiments. IP: immunoprecipitate. Statistics, as compared with non transgenic 
control mice: *: P<0.05; **: P<0.01; ***: P<0.005.
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Supplementary Figure 4: Water deprivation test: Urine output was measured during a 
24 h b li ( hit l ) d 24 h t d i ti (bl k l ) i d i t l-  ase ne w e co umns  an  a -  wa er epr va on ac  co umns  per o  n con ro  
(C) and Inpp5k transgenic (Inpp5k) mice. Results are means ± SEM of 5 pairs of 4-month 
old male mice and are expressed in µl of urine output per minute and per g of body weight. 
